메뉴 건너뛰기




Volumn 734, Issue 1, 1999, Pages 55-61

Quantitative determination of efavirenz (DMP 266), a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection

Author keywords

DMP 266; Efavirenz

Indexed keywords

EFAVIRENZ; RNA DIRECTED DNA POLYMERASE INHIBITOR;

EID: 0032879058     PISSN: 13872273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-4347(99)00336-9     Document Type: Article
Times cited : (59)

References (10)
  • 2
    • 0344339769 scopus 로고    scopus 로고
    • Du Pont Pharmaceuticals Company, Sustiva (efavirenz capsules), prescribing information, 17 Sept.
    • Du Pont Pharmaceuticals Company, Sustiva (efavirenz capsules), prescribing information, 17 Sept. 1998; http://www.sustiva.com.
    • (1998)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.